MASSACESI, LUCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.259
EU - Europa 11.674
AS - Asia 2.113
AF - Africa 76
OC - Oceania 20
SA - Sud America 8
Continente sconosciuto - Info sul continente non disponibili 3
Totale 26.153
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.229
PL - Polonia 4.266
RU - Federazione Russa 3.176
IT - Italia 1.230
IE - Irlanda 972
SE - Svezia 702
SG - Singapore 619
CN - Cina 499
HK - Hong Kong 464
UA - Ucraina 450
DE - Germania 291
IN - India 207
FI - Finlandia 176
GB - Regno Unito 167
JO - Giordania 136
CH - Svizzera 92
VN - Vietnam 75
CI - Costa d'Avorio 55
FR - Francia 45
TR - Turchia 34
ES - Italia 32
CA - Canada 29
IR - Iran 27
NL - Olanda 26
SA - Arabia Saudita 22
SC - Seychelles 21
BE - Belgio 19
KR - Corea 16
AU - Australia 15
JP - Giappone 10
RO - Romania 9
CZ - Repubblica Ceca 6
BR - Brasile 5
NZ - Nuova Zelanda 5
AT - Austria 4
GR - Grecia 3
LT - Lituania 3
IL - Israele 2
NO - Norvegia 2
PE - Perù 2
PK - Pakistan 2
XK - ???statistics.table.value.countryCode.XK??? 2
BG - Bulgaria 1
CL - Cile 1
EU - Europa 1
LU - Lussemburgo 1
MX - Messico 1
SI - Slovenia 1
Totale 26.153
Salva come PNG Salva come JPEG
Città #
Warsaw 4.265
Santa Clara 2.167
Fairfield 1.384
Dublin 968
Chandler 869
Woodbridge 643
Ashburn 640
Jacksonville 586
Seattle 564
Cambridge 511
Singapore 502
Houston 500
Wilmington 447
Altamura 343
Lawrence 338
Hong Kong 282
Princeton 262
Ann Arbor 256
Florence 223
Beijing 207
Boston 204
Mumbai 179
Buffalo 140
Boardman 120
Kent 106
Milan 104
Bern 89
Moscow 89
Dearborn 88
Medford 88
San Diego 88
Shanghai 88
Dong Ket 63
New York 56
Abidjan 55
Falls Church 55
Norwalk 49
West Jordan 43
Rome 41
Los Angeles 37
Helsinki 33
Phoenix 32
Barcelona 30
Yubileyny 30
Frankfurt Am Main 27
Hillsboro 27
Auburn Hills 25
Bremen 24
Toronto 22
Brussels 19
Riyadh 19
Verona 19
Arezzo 18
Izmir 17
London 16
Andover 14
Seoul 14
Guangzhou 12
Lappeenranta 12
Redwood City 10
Palermo 9
Pune 9
Bologna 8
Istanbul 8
Livorno 8
Melbourne 8
Nanjing 8
Romola 8
Hefei 7
Lucca 7
Padova 7
Amman 6
Bedwas 6
Brno 6
Catania 6
Edinburgh 6
Genoa 6
Iasi 6
Kunming 6
Munich 6
Amsterdam 5
Redmond 5
Salerno 5
Sydney 5
Tehran 5
Tokyo 5
Wuhan 5
Campi Bisenzio 4
Chennai 4
Chicago 4
Chorley 4
Forlì 4
Houplin-Ancoisne 4
Jinan 4
Laurel 4
Naples 4
Prescot 4
Reggio Emilia 4
Auckland 3
Bari 3
Totale 18.385
Salva come PNG Salva come JPEG
Nome #
Proposal for a New Score-Based Approach To Improve Efficiency of Diagnostic Laboratory Workflow for Acute Bacterial Meningitis in Adults 349
SWI enhances vein detection using gadolinium in multiple sclerosis. 265
The role of prolactin in autoimmune demyelination: suppression of experimental allergic encephalomyelitis by bromocriptine. 262
A synthetic glycopeptide of human myelin oligodendrocyte glycoprotein to detect antibody responses in multiple sclerosis and other neurological diseases. 259
Magnetic resonance imaging of experimental autoimmune encephalomyelitis in the common marmoset. 257
A linkage analysis of Multiple Sclerosis with candidate region markers in Sardinian and Continental Italian families. 252
Markers of JC virus infection in patients with multiple sclerosis under natalizumab therapy. 251
Increased CXCL10 expression in MS MSCs and monocytes is unaffected by AHSCT 248
Safety and efficacy of opicinumab in acute optic neuritis (RENEW): a randomised, placebo-controlled, phase 2 trial. 248
Fetal striatal grafting slows motor and cognitive decline of Huntington's disease 246
Azathioprine versus Beta Interferons for relapsing-remitting multiple sclerosis: a multicentre randomized non-inferiority trial. 243
A 12-month prospective, observational study evaluating the impact of disease-modifying treatment on emotional burden in recently-diagnosed multiple sclerosis patients: The POSIDONIA study 242
Active and passively induced experimental autoimmune encephalomyelitis in common marmosets: a new model for multiple sclerosis. 241
No proinflammatory signature in CD34+ hematopoietic progenitor cells in multiple sclerosis patients. 241
The central vein sign and its clinical evaluation for the diagnosis of multiple sclerosis: a consensus statement from the North American Imaging in Multiple Sclerosis Cooperative. 240
Survey of the italian neurological output in the three years 1989-1991. 239
Lysosomal enzymes in experimental allergic encephalomyelitis: time course and evidence of the source. 239
Central vein sign differentiates MS from CNS inflammatory vasculopathies. 230
In healthy primates, circulating autoreactive T-cells mediate autoimmune disease. 229
Experimental allergic encephalomyelitis in Cynomolgus Monkeys: quantitation of T-cell responses in peripheral blood. 228
Efficacy and safety of venous angioplasty of the extracranial veins for multiple sclerosis. Brave dreams study (brain venous drainage exploited against multiple sclerosis): study protocol for a randomized controlled trial 223
Efficacy and Safety of Extracranial Vein Angioplasty in Multiple Sclerosis: A Randomized Clinical Trial. 217
Expression of accessory molecules and cytokines in acute EAE in marmoset monkeys (Callithrix jacchus). 216
The formation of inflammatory demyelinated lesions in cerebral white matter. 211
Immunosuppressive activity of 13-cis retinoic acid and prevention of experimental autoimmune encephalomyelitis in rats. 209
Histopathological characterization of magnetic resonance imaging-decectable brain white matter lesions in a primate model of multiple sclerosis. 207
Effect of Interferon-β1b on Magnetic Resonance Imaging Outcomes in Secondary Progressive Multiple Sclerosis: Results of a European Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial. 200
Cyclophosphamide Pulse Therapy after Natalizumab Discontinuation for Multiple Sclerosis: a multicenter study. 198
The Italian multiple sclerosis register. 198
Placebo-controlled multicentre randomised trial of Interferon beta-1b in treatment of secondary progressive multiple sclerosis. 190
Safety of the first dose of fingolimod for multiple sclerosis: results of an open-label clinical trial. 184
Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension. 170
Carbon nanotube scaffolds instruct human dendritic cells: modulating immune responses by contacts at the nanoscale. 169
Environmental modifiable risk factors for multiple sclerosis: Report from the 2016 ECTRIMS focused workshop 166
Next Generation Molecular Diagnosis of Hereditary Spastic Paraplegias: An Italian Cross-Sectional Study 164
Operationalizing mild cognitive impairment criteria in small vessel disease: The VMCI-Tuscany Study 163
Autologous Hematopoietic Stem Cell Transplantation in Multiple Sclerosis: a phase II trial. 157
The “central vein sign” in patients with diagnostic “red flags” for multiple sclerosis: A prospective multicenter 3T study 150
New approaches to the study of T-cell autoimmunity in multiple sclerosis. 142
The TCR Repertoire Reconstitution in Multiple Sclerosis: Comparing One-Shot and Continuous Immunosuppressive Therapies 138
A key role for poly(ADP-ribose) polymerase-1 activity during human dendritic cell maturation. 137
Predictors of response to opicinumab in acute optic neuritis 136
T-cell autoimmunity in multiple sclerosis. 134
Safety and efficacy of autologous hematopoietic stem cell transplantation following natalizumab discontinuation in aggressive Multiple Sclerosis. 131
Decrypting the Spectrum of Antigen-Specific T-Cell Responses: The Avidity Repertoire of MBP-Specific T-Cells. 131
Disease reactivation following fingolimod withdrawal in multiple sclerosis: Two case reports. 128
Lipoderivatives of an immunodominant epitope of myelin basic protein increased T cell responsiveness in Lewis rats. 127
Immunohistochemistry analysis of bone marrow biopsies in multiple sclerosis patients undergoing autologous haematopoietic stem cells transplantation 126
Antibodies specific for the lipid-bound form of myelin basic protein during experimental autoimmune encephalomyelitis. 123
Il trapianto autologo di midollo osseo Intensa immunosoppressione seguita da trapianto autologo di cellule staminali in pazienti con forma grave di SM: dati clinici e RM. In L’interferone beta ed altre possibilità terapeutiche. 123
Long-term Outcomes After Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis. 121
SYNTHESIS OF LIPOPEPTIDES OF THE IMMUNODOMINANT EPITOPE HMBP(83-99) CONTAINING AMIDE OR C-C BOND LINKED HYDROPHOBIC CHAINS FOR THE STUDY OF T CELL RESPONSE 119
Subgroup Comparison According to Clinical Phenotype and Serostatus in Autoimmune Encephalitis: A Multicenter Retrospective Study 119
A genome screen for multiple sclerosis in Italian families. 115
Effects of pixantrone on immune-cell function in the course of acute rat experimental allergic encephalomyelitis. 115
Differences in mesenchymal stem cell cytokine profiles between MS patients and healthy donors: Implication for assessment of disease activity and treatment 115
A sequence variation in the MOG gene is involved in Multiple Sclerosis susceptibility in Italy. 115
Perivenular brain lesions in a primate multiple sclerosis model at 7-tesla magnetic resonance imaging. 114
The affinity spectrum of myelin basic protein reactive T cells. 113
Multiple sclerosis and Type I diabetes. 113
Diagnostics of the neuromyelitis optica spectrum disorders (NMOSD). 113
Induction of experimental autoimmune encephalomyelitis in rats and immune response to myelin basic protein in lipid bound form. 113
Clinical characteristics predicting relapses following disease modifying therapies discontinuation in multiple sclerosis: a monocentric cohort study 113
Anti-SARS-Cov2 vaccination at the time of the COVID-19 pandemic: suspected adverse events reporting is the milestone of post-marketing surveillance 113
A whole genome screen for linkage disequilibrium in multiple sclerosis performed in a continental Italian population. 112
Detection of JCPyV microRNA in blood and urine samples of multiple sclerosis patients under natalizumab therapy. 112
Multiple sclerosis in twins from continental Italy and Sardinia: A nationwide study. 110
Experimental allergic encephalomyelitis and multiple sclerosis: immunoregulatory mechanisms and T cell repertoires. 110
Protein tyrosine phosphatase receptor-type C exon 4 gene mutation distribution in an Italian multiple sclerosis population. 110
Autologous HSCT for severe progressive multiple sclerosis in a multicenter trial: impact on disease activity and quality of life. 110
Modulating dendritic cells (DC) from immunogenic to tolerogenic responses: a novel mechanism of AZA/6-MP. 110
Kynurenine 3-mono-oxygenase activity and neurotoxic kynurenine metabolites increase in the spinal cord of rats with experimental allergic encephalomyelitis. 108
Prolactin and prolactin receptor gene polymorphisms in multiple sclerosis and systemic lupus erythematosus. 108
Suppression of experimental allergic encephalomyelitis by retinoic acid. 108
Autologous haematopoietic stem cell transplantation with an intermediate intensity conditioning regimen in multiple sclerosis: The Italian multi-centre experience 108
EFFECT OF LIPOCONJUGATION ON MBP PEPTIDE EPITOPES FOR CD4+ T CELL RESPONSIVENESS 107
Inhibition of Immune Synapse by Altered Dendritic CellActin Distribution: A New Pathway of Mesenchymal StemCell Immune Regulation. 107
Segregation of Immunoglobulin heavy Chain constant region genes in Multiple sclerosis sibling pairs. 105
Central nervous system involvement in systemic lupus erythematosus patients without overt neuropsychiatric manifestations. 105
[Asn31(N-beta-D-Glucopyranosyl)]hMOG(30-50): an antigen to identify anti-hMOG peptide antibodies in multiple sclerosis patients. 105
Short-term dynamics of circulating T cell receptor V beta repertoire in relapsing-remitting MS. 104
The long-term effect of AHSCT on MRI measures of MS evolution: a five-year follow-up study. 103
Short-term evolution of autoreactive T-cell repertoire in multiple sclerosis. 103
HLA A2 allele is associated with age at onset of Alzheimer's disease. 103
Prevalence of neuromyelitis optica spectrum disorder and phenotype distribution. 103
Efficacy of Azathioprine on Multiple Sclerosis new brain lesions evaluated using Magnetic Resonance Imaging. 103
LIPOPHILIC MODIFICATIONS OF PEPTIDE EPITOPES: T-CELL RESPONSE AND SUSCEPTIBILITY TO PEPTIDASES 103
A new primate model for multiple sclerosis in the common marmoset. 102
Palmitoyl Derivatives of GpMBP Epitopes: T-Cell Response and Peptidases Susceptibility. 102
Immunosuppressive activity of 13-cis-retinoic acid in rats: aspects of pharmacokinetics and pharmacodynamics. 101
Use of technetium-99m hexamethylpropylene amine oxime single-photon emission tomography for the study of cerebral blood flow reactivity after acetazolamide infusion in patients with Behçet’s disease. 101
Suppression of experimental allergic encephalomyelitis by retinoic acid. 101
DNA changes in spinal cords of rats with experimental allergic encephalomyelitis. 101
Gadolinium improves susceptibility weighted imaging vein detection in multiple sclerosis white matter contrast enhancing lesions. 101
Effect of disease-modifying treatments on antibody-mediated response to anti- COVID19 vaccination in people with multiple sclerosis 101
Severe disease reactivation in two multiple sclerosis patients after natalizumab withdrawal was not halted by monthly administrations of cyclophosphamide - two case reports 99
Association of apolipoprotein E polymorphism to clinical heterogeneity of multiple sclerosis. 99
Autologous stem cell transplantation for progressive multiple sclerosis: update of the European Group for Blood and Marrow Transplantation auto immune diseases working party database. 98
Combined treatment with atorvastatin and minocycline suppresses severity of EAE 98
Demyelination and axonal damage in a non-human primate model of multiple sclerosis. 96
Totale 15.345
Salva come PNG Salva come JPEG
Categoria #
all - tutte 71.940
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 71.940
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.191 0 0 0 0 526 517 428 543 384 293 429 71
2020/20212.720 216 240 189 332 152 318 132 256 194 387 100 204
2021/20221.677 55 211 79 117 57 67 65 134 78 70 281 463
2022/20234.386 376 853 221 231 335 769 584 240 489 20 135 133
2023/20241.920 75 236 268 114 161 180 75 352 48 132 177 102
2024/20257.153 517 1.247 794 1.848 2.747 0 0 0 0 0 0 0
Totale 26.501